|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101,400 KRW | -1.74% |
|
-0.49% | -22.54% |
Chong Kun Dang Pharmaceutical Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 5,958.63 million compared to KRW 8,585.42 million a year ago.
Net income was KRW 35,852.02 million compared to KRW 17,424.6 million a year ago. Basic earnings per share from continuing operations was KRW 2,947 compared to KRW 1,415 a year ago. Basic earnings per share was KRW 2,947 compared to KRW 1,415 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -22.54% | 945M | |
| +22.69% | 43.81B | |
| +25.56% | 23.01B | |
| +18.96% | 15.27B | |
| +8.91% | 13.68B | |
| +42.72% | 11.96B | |
| -7.49% | 6.98B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.26% | 5.59B |
CHONG KUN DANG PHARMACEUTICAL CORP. 
